866-997-4948(US-Canada Toll Free)

Late-stage chronic kidney disease (CKD) - Market Insights, Epidemiology and Market Forecast-2023

Published By :

DelveInsight

Published Date : Jan 2017

Category :

Pharmaceutical

No. of Pages : 100 Pages

 


Note*: This report requires 5-7 business days to complete.
DelveInsights Late-stage chronic kidney disease (CKD) - Market Insights, Epidemiology and Market Forecast-2023 Reports provides an overview of the disease and global market trends of the Indication for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Late-stage chronic kidney disease (CKD) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Late-stage chronic kidney disease (CKD) till 2023.


Key Coverage and Benefits

The report will help in developing business strategies by understanding the trends shaping and driving the global Late-stage chronic kidney disease (CKD) market.
Identifying patient populations in the global Late-stage chronic kidney disease (CKD)market to improve product design, pricing, and launch plans.
Organize sales and marketing efforts by identifying the best opportunities for Late-stage chronic kidney disease (CKD) therapeutics in each of the markets covered.
To understand the future market competition in the global Late-stage chronic kidney disease (CKD) therapeutics market and Insightful review of the key market drivers and barriers.


Scope

Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
It also provides Late-stage chronic kidney disease (CKD) for United States, EU5 and Japan from 2013 and forecasted Market to 2023.


 

 

 


Late-stage chronic kidney disease (CKD) overview
Pathophysiology
Symptoms of disease
Etiology of disease
Diagnosis of disease
Treatment of disease
Overview of Marketed drugs
Drug Description
Mechanism of Action
Pharmacokinetics Properties
Marketed Details
Patent Information
Patent Exclusivity Expiry Assessment United States (US)
Patents Details
Historical and Forecasted sales of marketed molecules in the Global Late-stage chronic kidney disease (CKD) Market
Global Epidemiology of Late-stage chronic kidney disease (CKD) Forecasted to 2023
Global Market (2013-2015)
Global Forecasted Market (2016-2023)
Global Market by Geography
Market of US (2013-2015)
Forecasted Market of US (2016-2023)
Market of Europe
Market of Germany (2013-2015)
Forecasted Market of Germany (2016-2023)
Market of United Kingdom (2013-2015)
Forecasted Market of United Kingdom (2016-2023)
Market of France (2013-2015)
Forecasted Market of France (2016-2023)
Market of Italy (2013-2015)
Forecasted Market of Italy (2016-2023)
Market of Spain (2013-2015)
Forecasted Market of Spain (2016-2023)
Market of Japan (2013-2015)
Forecasted Market of Japan (2016-2023)
Market of ROW (2013-2015)
Forecasted Market of ROW (2016-2023)
Appendix
Report Methodology
Consulting Services
Disclaimer
Report Purchase Options
About DelveInsight




List of Tables


Table 1: Drug Description
Table 2: Drug, Marketed Details United States (US)
Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
Table 4: Drug, Patent Details for US
Table 5: Late-stage chronic kidney disease (CKD) Drug Sales (USD Millions)-2023
Table 6: Global Epidemiology of Late-stage chronic kidney disease (CKD) (2013-2023)
Table 7: Late-stage chronic kidney disease (CKD) Global Market (USD Millions), (2013-2015)
Table 8: Late-stage chronic kidney disease (CKD) Global Market (USD Millions), (2016-2023)
Table 9: Late-stage chronic kidney disease (CKD) US Market (USD Millions), (2013-2015)
Table 10: Late-stage chronic kidney disease (CKD) US Market (USD Millions), (2016-2023)
Table 11: Late-stage chronic kidney disease (CKD) Germany Market (USD Millions), (2013-2015)
Table 12: Late-stage chronic kidney disease (CKD) Germany Market (USD Millions), (2016-2023)
Table 13: Late-stage chronic kidney disease (CKD) United Kingdom Market (USD Millions), (2013-2015)
Table 14: Late-stage chronic kidney disease (CKD) United Kingdom Market (USD Millions), (2016-2023)
Table 15: Late-stage chronic kidney disease (CKD) France Market (USD Millions), (2013-2015)
Table 16: Late-stage chronic kidney disease (CKD) France Market (USD Millions), (2016-2023)
Table 17: Late-stage chronic kidney disease (CKD) Italy Market (USD Millions), (2013-2015)
Table 18: Late-stage chronic kidney disease (CKD) Italy Market (USD Millions), (2016-2023)
Table 19: Late-stage chronic kidney disease (CKD) Spain Market (USD Millions), (2013-2015)
Table 20: Late-stage chronic kidney disease (CKD) Spain Market (USD Millions), (2016-2023)
Table 21: Late-stage chronic kidney disease (CKD) Japan Market (USD Millions), (2013-2015)
Table 22: Late-stage chronic kidney disease (CKD) Japan Market (USD Millions), (2016-2023)
Table 23: Late-stage chronic kidney disease (CKD) ROW Market (USD Millions), (2013-2015)
Table 24: Late-stage chronic kidney disease (CKD) ROW Market (USD Millions), (2016-2023)


List of Figures


Figure 1: Late-stage chronic kidney disease (CKD) Drug Sales (USD Millions)-2023
Figure 2: Global Epidemiology of Late-stage chronic kidney disease (CKD) (2013-2023)
Figure 3: Late-stage chronic kidney disease (CKD) Global Market (USD Millions), (2013-2015)
Figure 4: Late-stage chronic kidney disease (CKD) Global Market (USD Millions), (2016-2023)
Figure 5: Late-stage chronic kidney disease (CKD) US Market (USD Millions), (2013-2015)
Figure 6: Late-stage chronic kidney disease (CKD) US Market (USD Millions), (2016-2023)
Figure 7: Late-stage chronic kidney disease (CKD) Germany Market (USD Millions), (2013-2015)
Figure 8: Late-stage chronic kidney disease (CKD) Germany Market (USD Millions), (2016-2023)
Figure 9: Late-stage chronic kidney disease (CKD) United Kingdom Market (USD Millions), (2013-2015)
Figure 10: Late-stage chronic kidney disease (CKD) United Kingdom Market (USD Millions), (2016-2023)
Figure 11: Late-stage chronic kidney disease (CKD) France Market (USD Millions), (2013-2015)
Figure 12: Late-stage chronic kidney disease (CKD) France Market (USD Millions), (2016-2023)
Figure 13: Late-stage chronic kidney disease (CKD) Italy Market (USD Millions), (2013-2015)
Figure 14: Late-stage chronic kidney disease (CKD) Italy Market (USD Millions), (2016-2023)
Figure 15: Late-stage chronic kidney disease (CKD) Spain Market (USD Millions), (2013-2015)
Figure 16: Late-stage chronic kidney disease (CKD) Spain Market (USD Millions), (2016-2023)
Figure 17: Late-stage chronic kidney disease (CKD) Japan Market (USD Millions), (2013-2015)
Figure 18: Late-stage chronic kidney disease (CKD) Japan Market (USD Millions), (2015-2023)
Figure 19: Late-stage chronic kidney disease (CKD) ROW Market (USD Millions), (2013-2015)
Figure 20: Late-stage chronic kidney disease (CKD) ROW Market (USD Millions), (2016-2023)


 

 

List of Table

Table 1: Drug Description
Table 2: Drug, Marketed Details United States (US)
Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
Table 4: Drug, Patent Details for US
Table 5: Late Drug Sales (USD Millions)
Table 6: Global Epidemiology of Late(2013-2023)
Table 7: Late Global Market (USD Millions), (2013-2015)
Table 8: Late Global Market (USD Millions), (2016-2023)
Table 9: Late US Market (USD Millions), (2013-2015)
Table 10: Late US Market (USD Millions), (2016-2023)
Table 11: Late Germany Market (USD Millions), (2013-2015)
Table 12: Late Germany Market (USD Millions), (2016-2023)
Table 13: Late United Kingdom Market (USD Millions), (2013-2015)
Table 14: Late United Kingdom Market (USD Millions), (2016-2023)
Table 15: Late France Market (USD Millions), (2013-2015)
Table 16: Late France Market (USD Millions), (2016-2023)
Table 17: Late Italy Market (USD Millions), (2013-2015)
Table 18: Late Italy Market (USD Millions), (2016-2023)
Table 19: Late Spain Market (USD Millions), (2013-2015)
Table 20: Late Spain Market (USD Millions), (2016-2023)
Table 21: Late Japan Market (USD Millions), (2013-2015)
Table 22: Late Japan Market (USD Millions), (2016-2023)
Table 23: Late ROW Market (USD Millions), (2013-2015)
Table 24: Late ROW Market (USD Millions), (2016-2023)

List of Chart

Figure 1: Late Drug Sales (USD Millions)
Figure 2: Global Epidemiology of Late(2013-2023)
Figure 3: Late Global Market (USD Millions), (2013-2015)
Figure 4: Late Global Market (USD Millions), (2016-2023)
Figure 5: Late US Market (USD Millions), (2013-2015)
Figure 6: Late US Market (USD Millions), (2016-2023)
Figure 7: Late Germany Market (USD Millions), (2013-2015)
Figure 8: Late Germany Market (USD Millions), (2016-2023)
Figure 9: Late United Kingdom Market (USD Millions), (2013-2015)
Figure 10: Late United Kingdom Market (USD Millions), (2016-2023)
Figure 11: Late France Market (USD Millions), (2013-2015)
Figure 12: Late France Market (USD Millions), (2016-2023)
Figure 13: Late Italy Market (USD Millions), (2013-2015)
Figure 14: Late Italy Market (USD Millions), (2016-2023)
Figure 15: Late Spain Market (USD Millions), (2013-2015)
Figure 16: Late Spain Market (USD Millions), (2016-2023)
Figure 17: Late Japan Market (USD Millions), (2013-2015)
Figure 18: Late Japan Market (USD Millions), (2015-2023)
Figure 19: Late ROW Market (USD Millions), (2013-2015)
Figure 20: Late ROW Market (USD Millions), (2016-2023)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *